Mikes Beverly A., Vadakekut Elsa S., Sparzak Paul B.
Virtua Hospital
American College of Osteopathic Obstetricians and Gynecologists
Abnormal uterine bleeding (AUB) is a broad term that describes irregularities in the menstrual cycle involving the parameters of frequency, regularity, duration, and volume of flow outside of pregnancy in reproductive-aged women. (Please see StatPearls' companion resources, "Postmenopausal Bleeding," for more information on diagnosis and management in postmenopausal women). Up to one-third of women will experience AUB in their life, with irregularities most commonly occurring at menarche and perimenopause. A normal menstrual cycle has a frequency of 24 to 38 days and lasts 2 to 7 days, with 5 to 80 mL of blood loss. Therefore, variations in any of these 4 parameters constitute AUB. AUB terminology and classification have evolved to promote clarity and uniformity in diagnosis. Revisions to AUB terminology were first published in 2007, followed by updates from the International Federation of Obstetrics and Gynecology (FIGO) in 2011 and 2018. In 2007, FIGO System 1 established more defined descriptive terms nongestational AUB based on the frequency, regularity, duration, and volume of flow. The nonspecific terminology of menorrhagia, metrorrhagia, and oligomenorrhea was also replaced with the terms heavy menstrual bleeding (HMB) characterized by bleeding >80 mL or heavy enough to interfere with a patient's qualify of life, intermenstrual bleeding (ie, cyclical or random spontaneous bleeding between menstrual periods) and breakthrough bleeding (BTB) on hormone medication. (Please refer to the section for more information on AUB descriptions). FIGO System 2 introduced PALM-COEIN, which categorizes AUB into structural (polyp, adenomyosis, leiomyoma, malignancy/hyperplasia) and nonstructural (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not otherwise classified) etiologies. The committee also defined irregular bleeding as any bleeding that falls outside the 5th to 95th percentiles for any menstrual parameter (eg, regularity, frequency, duration, and volume). AUB can also be divided into acute and chronic bleeding. Acute AUB is excessive bleeding that requires immediate intervention to prevent further blood loss. Acute AUB can occur on its own or superimposed on chronic AUB, which refers to irregularities in menstrual bleeding for most of the previous 6 months. Understanding acute versus chronic AUB helps clinicians tailor evaluation and management strategies, ensuring optimal patient outcomes. Evaluation involves a detailed history, physical examination, laboratory tests, and diagnostic imaging or endometrial sampling when indicated. Management approaches primarily treat the underlying etiology and optimize bleeding with strategies individualized based on AUB severity, cause, and patient preference.
异常子宫出血(AUB)是一个广义术语,用于描述育龄期女性非孕期月经周期在频率、规律性、持续时间和出血量等参数方面的异常情况。(有关绝经后女性诊断和管理的更多信息,请参阅StatPearls的配套资源“绝经后出血”)。多达三分之一的女性一生中会经历AUB,异常情况最常发生在初潮和围绝经期。正常月经周期频率为24至38天,持续2至7天,失血量为5至80毫升。因此,这4个参数中任何一个发生变化都构成AUB。AUB的术语和分类不断演变,以促进诊断的清晰性和一致性。AUB术语的修订于2007年首次发布,随后国际妇产科联合会(FIGO)在2011年和2018年进行了更新。2007年,FIGO系统1基于频率、规律性、持续时间和出血量建立了更明确的非妊娠性AUB描述术语。月经过多、子宫出血和月经过少等非特异性术语也被以下术语取代:月经过多(HMB),其特征为出血量>80毫升或严重到足以影响患者生活质量;经间期出血(即月经周期之间的周期性或随机自发性出血);以及激素用药时的突破性出血(BTB)。(有关AUB描述的更多信息,请参阅该部分内容)。FIGO系统2引入了PALM-COEIN,将AUB分为结构性(息肉、子宫腺肌病、平滑肌瘤、恶性肿瘤/增生)和非结构性(凝血功能障碍、排卵功能障碍、子宫内膜病变、医源性、未另行分类)病因。该委员会还将不规则出血定义为任何月经参数(如规律性、频率、持续时间和出血量)超出第5至95百分位数的出血。AUB也可分为急性出血和慢性出血。急性AUB是指需要立即干预以防止进一步失血的过量出血。急性AUB可单独发生,也可叠加在慢性AUB之上,慢性AUB是指过去6个月中大部分时间月经出血异常。了解急性与慢性AUB有助于临床医生制定评估和管理策略,确保患者获得最佳治疗效果。评估包括详细的病史、体格检查、实验室检查,以及在必要时进行诊断性影像学检查或子宫内膜取样。管理方法主要是治疗潜在病因,并根据AUB的严重程度、病因和患者偏好,采用个体化策略优化出血情况。